Healthy men test new semaglutide pill: water and breakfast timing matter
NCT ID NCT05996874
First seen Nov 01, 2025 · Last updated Apr 25, 2026 · Updated 28 times
Summary
This study tested a new tablet form of semaglutide (a diabetes drug) in 121 healthy men. Researchers wanted to see how different amounts of water (50 or 120 mL) and delays before breakfast (30, 60, or 120 minutes) affect drug levels in the blood. Participants took one tablet daily for 10 days. The results will help improve dosing instructions for people with type 2 diabetes.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY PARTICIPANTS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Profil Institut für Stoffwechselforschung GmbH
Neuss, 41460, Germany
Conditions
Explore the condition pages connected to this study.